{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:40:10Z","timestamp":1790048410701,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1124\/jpet.105.099499","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T01:48:48Z","timestamp":1138326528000},"page":"514-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Antiproliferative Drug Doxorubicin Inhibits Liver Fibrosis in Bile Duct-Ligated Rats and Can Be Selectively Delivered to Hepatic Stellate Cells in Vivo"],"prefix":"10.1016","volume":"317","author":[{"given":"Rick","family":"Greupink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester I.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Reker-Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk K.F.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.099499_bib1","doi-asserted-by":"crossref","unstructured":"Bataller R and Brenner DA (2005) Liver fibrosis. J Clin Investig 115: 209\u2013218.","DOI":"10.1172\/JCI200524282"},{"key":"10.1124\/jpet.105.099499_bib2","doi-asserted-by":"crossref","unstructured":"Beljaars L, Molema G, Schuppan D, Geerts A, de Bleser PJ, Weert B, Meijer DK, and Poelstra K (2000) Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J Biol Chem 275: 12743\u201312751.","DOI":"10.1074\/jbc.275.17.12743"},{"key":"10.1124\/jpet.105.099499_bib3","doi-asserted-by":"crossref","unstructured":"Beljaars L, Molema G, Weert B, Bonnema H, Olinga P, Groothuis GM, Meijer DK, and Poelstra K (1999) Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology 29: 1486\u20131493.","DOI":"10.1002\/hep.510290526"},{"key":"10.1124\/jpet.105.099499_bib4","doi-asserted-by":"crossref","unstructured":"Beljaars L, Weert B, Geerts A, Meijer DK, and Poelstra K (2003) The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochem Pharmacol 66: 1307\u20131317.","DOI":"10.1016\/S0006-2952(03)00445-3"},{"key":"10.1124\/jpet.105.099499_bib5","doi-asserted-by":"crossref","unstructured":"Bland KI, Palin WE, von Fraunhofer JA, Morris RR, Adcock RA, and Tobin GR (1984) Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 199: 782\u2013790.","DOI":"10.1097\/00000658-198406000-00017"},{"key":"10.1124\/jpet.105.099499_bib6","doi-asserted-by":"crossref","unstructured":"Bosma A, Seifert WF, van Thiel-de Ruiter GC, van Leeuwen RE, Blauw B, Roholl P, Knook DL, and Brouwer A (1994) Alcohol in combination with malnutrition causes increased liver fibrosis in rats. J Hepatol 21: 394\u2013402.","DOI":"10.1016\/S0168-8278(05)80319-8"},{"key":"10.1124\/jpet.105.099499_bib7","doi-asserted-by":"crossref","unstructured":"Braulke T and Mieskes G (1992) Role of protein phosphatases in insulin-like growth factor II (IGF II)-stimulated mannose 6-phosphate\/IGF II receptor redistribution. J Biol Chem 267: 17347\u201317353.","DOI":"10.1016\/S0021-9258(18)41932-1"},{"key":"10.1124\/jpet.105.099499_bib8","doi-asserted-by":"crossref","unstructured":"Caligiuri A, De Franco RM, Romanelli RG, Gentilini A, Meucci M, Failli P, Mazzetti L, Rombouts K, Geerts A, Vanasia M, et al. (2003) Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells. Gastroenterology 124: 504\u2013520.","DOI":"10.1053\/gast.2003.50058"},{"key":"10.1124\/jpet.105.099499_bib9","doi-asserted-by":"crossref","unstructured":"Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, and Gores GJ (2004) The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 308: 1191\u20131196.","DOI":"10.1124\/jpet.103.060129"},{"key":"10.1124\/jpet.105.099499_bib10","doi-asserted-by":"crossref","unstructured":"Dahms NM and Hancock MK (2002) P-type lectins. Biochim Biophys Acta 1572: 317\u2013340.","DOI":"10.1016\/S0304-4165(02)00317-3"},{"key":"10.1124\/jpet.105.099499_bib11","doi-asserted-by":"crossref","unstructured":"de Bleser PJ, Jannes P, van Buul-Offers SC, Hoogerbrugge CM, van Schravendijk CF, Niki T, Rogiers V, van den Brande JL, Wisse E, and Geerts A (1995) Insulin-like growth factor-II\/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology 21: 1429\u20131437.","DOI":"10.1002\/hep.1840210529"},{"key":"10.1124\/jpet.105.099499_bib12","doi-asserted-by":"crossref","unstructured":"de Bleser PJ, Scott CD, Niki T, Xu G, Wisse E, and Geerts A (1996) Insulin-like growth factor II\/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat. Hepatology 23: 1530\u20131537.","DOI":"10.1002\/hep.510230633"},{"key":"10.1124\/jpet.105.099499_bib13","doi-asserted-by":"crossref","unstructured":"Di Sario A, Bendia E, Svegliati BG, Ridolfi F, Casini A, Ceni E, Saccomanno S, Marzioni M, Trozzi L, Sterpetti P, et al. (2002) Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. J Hepatol 37: 584\u2013591.","DOI":"10.1016\/S0168-8278(02)00245-3"},{"key":"10.1124\/jpet.105.099499_bib14","doi-asserted-by":"crossref","unstructured":"Di Sario A, Bendia E, Taffetani S, Marzioni M, Candelaresi C, Pigini P, Schindler U, Kleemann HW, Trozzi L, Macarri G, et al. (2003) Selective Na+\/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. Hepatology 37: 256\u2013266.","DOI":"10.1053\/jhep.2003.50028"},{"key":"10.1124\/jpet.105.099499_bib15","doi-asserted-by":"crossref","unstructured":"Eng FJ and Friedman SL (2000) Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol 279: G7\u2013G11.","DOI":"10.1152\/ajpgi.2000.279.1.G7"},{"key":"10.1124\/jpet.105.099499_bib16","doi-asserted-by":"crossref","unstructured":"Fausto N (2004) Liver regeneration and repair: hepatocytes, progenitor cells and stem cells. Hepatology 39: 1477\u20131487.","DOI":"10.1002\/hep.20214"},{"key":"10.1124\/jpet.105.099499_bib17","doi-asserted-by":"crossref","unstructured":"Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247\u20132250.","DOI":"10.1074\/jbc.275.4.2247"},{"key":"10.1124\/jpet.105.099499_bib18","doi-asserted-by":"crossref","unstructured":"Geerts A (2001) History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells. Semin Liver Dis 21: 311\u2013335.","DOI":"10.1055\/s-2001-17550"},{"key":"10.1124\/jpet.105.099499_bib19","doi-asserted-by":"crossref","unstructured":"Geerts A, Niki T, Hellemans K, De Craemer D, Van Den Berg K, Lazou JM, Stange G, van De Winkel M, and De Bleser P (1998) Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology 27: 590\u2013598.","DOI":"10.1002\/hep.510270238"},{"key":"10.1124\/jpet.105.099499_bib20","doi-asserted-by":"crossref","unstructured":"Gewirtz DA (1999) A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727\u2013741.","DOI":"10.1016\/S0006-2952(98)00307-4"},{"key":"10.1124\/jpet.105.099499_bib21","doi-asserted-by":"crossref","unstructured":"Gigliozzi A, Fraioli F, Sundaram P, Lee J, Mennone A, Alvaro D, and Boyer JL (2000) Molecular identification and functional characterization of Mdr1a in rat cholangiocytes. Gastroenterology 119: 1113\u20131122.","DOI":"10.1053\/gast.2000.18156"},{"key":"10.1124\/jpet.105.099499_bib22","doi-asserted-by":"crossref","unstructured":"Greupink R, Bakker HI, Reker-Smit C, Loenen-Weemaes AM, Kok RJ, Meijer DK, Beljaars L, and Poelstra K (2005) Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. J Hepatol 43: 884\u2013892.","DOI":"10.1016\/j.jhep.2005.04.014"},{"key":"10.1124\/jpet.105.099499_bib23","unstructured":"Griffiths GL, Mattes MJ, Stein R, Govindan SV, Horak ID, Hansen HJ, and Goldenberg DM (2003) Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate. Clin Cancer Res 9: 6567\u20136571."},{"key":"10.1124\/jpet.105.099499_bib24","doi-asserted-by":"crossref","unstructured":"Hagens WI, Olinga P, Meijer DKF, Grootnuis GMM, Beljaars L, and Poelstra K (2006) Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int 26: 232\u2013239.","DOI":"10.1111\/j.1478-3231.2005.01212.x"},{"key":"10.1124\/jpet.105.099499_bib25","doi-asserted-by":"crossref","unstructured":"Kurikawa N, Suga M, Kuroda S, Yamada K, and Ishikawa H (2003) An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol 139: 1085\u20131094.","DOI":"10.1038\/sj.bjp.0705339"},{"key":"10.1124\/jpet.105.099499_bib26","unstructured":"Moss DW and Henderson AR (1999) Clinical enzymology, in Tietz Textbook of Clinical Chemistry (Burtis CA and Ashwood ER eds) pp 686\u2013689, W. B. Saunders Company, Philadelphia, PA."},{"key":"10.1124\/jpet.105.099499_bib27","doi-asserted-by":"crossref","unstructured":"Niki T, Rombouts K, De Bleser P, De Smet K, Rogiers V, Schuppan D, Yoshida M, Gabbiani G, and Geerts A (1999) A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 29: 858\u2013867.","DOI":"10.1002\/hep.510290328"},{"key":"10.1124\/jpet.105.099499_bib28","doi-asserted-by":"crossref","unstructured":"Pinzani M, Rombouts K, and Colagrande S (2005) Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 42 (Suppl): S22\u2013S36.","DOI":"10.1016\/j.jhep.2004.12.008"},{"key":"10.1124\/jpet.105.099499_bib29","doi-asserted-by":"crossref","unstructured":"Poelstra K, Hardonk MJ, Koudstaal J, and Bakker WW (1990) Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 37: 1500\u20131508.","DOI":"10.1038\/ki.1990.141"},{"key":"10.1124\/jpet.105.099499_bib30","doi-asserted-by":"crossref","unstructured":"Rivera CA, Bradford BU, Hunt KJ, Adachi Y, Schrum LW, Koop DR, Burchardt ER, Rippe RA, and Thurman RG (2001) Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am J Physiol 281: G200\u2013G207.","DOI":"10.1152\/ajpgi.2001.281.1.G200"},{"key":"10.1124\/jpet.105.099499_bib31","doi-asserted-by":"crossref","unstructured":"Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, and Geerts A (2003) Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol 38: 564\u2013572.","DOI":"10.1016\/S0168-8278(03)00051-5"},{"key":"10.1124\/jpet.105.099499_bib32","doi-asserted-by":"crossref","unstructured":"Shen WC and Ryser HJ (1981) cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem Biophys Res Commun 102: 1048\u20131054.","DOI":"10.1016\/0006-291X(81)91644-2"},{"key":"10.1124\/jpet.105.099499_bib33","doi-asserted-by":"crossref","unstructured":"Wang YQ, Ikeda K, Ikebe T, Hirakawa K, Sowa M, Nakatani K, Kawada N, and Kaneda K (2000) Inhibition of hepatic stellate cell proliferation and activation by the semisynthetic analogue of fumagillin TNP-470 in rats. Hepatology 32: 989.","DOI":"10.1053\/jhep.2000.18658"},{"key":"10.1124\/jpet.105.099499_bib34","doi-asserted-by":"crossref","unstructured":"Wirth M, Fuchs A, Wolf M, Ertl B, and Gabor F (1998) Lectin-mediated drug targeting: preparation, binding characteristics and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells. Pharm Res (NY) 15: 1031\u20131037.","DOI":"10.1023\/A:1011926026653"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524326382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524326382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.099499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:50:28Z","timestamp":1740001828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524326382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0022356524326382"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.099499","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Antiproliferative Drug Doxorubicin Inhibits Liver Fibrosis in Bile Duct-Ligated Rats and Can Be Selectively Delivered to Hepatic Stellate Cells in Vivo","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.099499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}